Proskauer advised RiverVest Venture Partners on the deal.
RiverVest Venture Partners, a St. Louis-based venture capital firm, completed the closing of RiverVest Venture Fund V, L.P.
At $275 million, Fund V is RiverVest’s largest fund to date, with commitments from a wide range of institutional investors, as well as family offices and individual investors. The vehicle brings the firm’s total assets under management to more than $1.6 billion.
RiverVest invests in early-stage biopharma and medical device companies addressing significant unmet medical needs.
The Proskauer team advising RiverVest included partners Howard Beber (Picture) and Jim Poindexter, senior counsel Adam Scoll, and associates Emily O’Brien, Garabed Koosherian and Jeanette Stecker.
Involved fees earner: Howard Beber – Proskauer Rose LLP; Garabed Koosherian – Proskauer Rose LLP; Emily O’Brien – Proskauer Rose LLP; Jamiel Poindexter – Proskauer Rose LLP; Adam Scoll – Proskauer Rose LLP; Jeanette Stecker – Proskauer Rose LLP;
Law Firms: Proskauer Rose LLP;
Clients: RiverVest Venture Partners;